Roche believes it has exited phase 3 with data to support talks with regulatory agencies, but the mixed results raise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback